These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9718168)

  • 1. Improvements in pelvic exenteration: factors responsible for reducing morbidity and mortality.
    Goldberg JM; Piver MS; Hempling RE; Aiduk C; Blumenson L; Recio FO
    Ann Surg Oncol; 1998; 5(5):399-406. PubMed ID: 9718168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pelvic exenteration for recurrent or persistent gynecologic malignancies: a 10-year review of the Memorial Sloan-Kettering Cancer Center experience (1972-1981).
    Lawhead RA; Clark DG; Smith DH; Pierce VK; Lewis JL
    Gynecol Oncol; 1989 Jun; 33(3):279-82. PubMed ID: 2722049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pelvic exenteration for primary and recurrent gynaecological malignancies.
    de Wilt JH; van Leeuwen DH; Logmans A; Verhoef C; Kirkels WJ; Vermaas M; Ansink AC
    Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):243-8. PubMed ID: 16950559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of short-term surgical complications in women undergoing pelvic exenteration for gynecological malignancies.
    Tortorella L; Casarin J; Mara KC; Weaver AL; Multinu F; Glaser GE; Cliby WA; Scambia G; Mariani A; Kumar A
    Gynecol Oncol; 2019 Jan; 152(1):151-156. PubMed ID: 30414740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pelvic exenteration for gynecologic malignancies: The experience of a tertiary center from Greece.
    Haidopoulos D; Pergialiotis V; Aggelou K; Thomakos N; Alexakis N; Stamatakis E; Rodolakis A
    Surg Oncol; 2022 Mar; 40():101702. PubMed ID: 35065392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical results of pelvic exenteration in the treatment of gynecologic cancer.
    Petruzziello A; Kondo W; Hatschback SB; Guerreiro JA; Filho FP; Vendrame C; Luz M; Ribeiro R
    World J Surg Oncol; 2014 Sep; 12():279. PubMed ID: 25200866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of postoperative complications and quality of life between patients undergoing continent versus non-continent urinary diversion after pelvic exenteration for gynecologic malignancies.
    Angeles MA; Mallet E; Rouanet P; Cabarrou B; Méeus P; Lambaudie E; Foucher F; Narducci F; Loaec C; Gouy S; Guyon F; Marchal F; Gladieff L; Martínez-Gómez C; Migliorelli F; Martinez A; Ferron G
    Int J Gynecol Cancer; 2020 Feb; 30(2):233-240. PubMed ID: 31796531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pelvic exenteration as treatment of recurrent or advanced gynecologic and urologic cancer.
    Roos EJ; Van Eijkeren MA; Boon TA; Heintz AP
    Int J Gynecol Cancer; 2005; 15(4):624-9. PubMed ID: 16014116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of surgeon volume on outcomes after pelvic exenteration for a gynecologic cancer.
    Jalloul RJ; Nick AM; Munsell MF; Westin SN; Ramirez PT; Frumovitz M; Soliman PT
    J Gynecol Oncol; 2018 Sep; 29(5):e68. PubMed ID: 30022632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pelvic exenteration for gynecologic malignancies: Postoperative complications and oncologic outcomes.
    Romeo A; Gonzalez MI; Jaunarena J; Zubieta ME; Favre G; Tejerizo JC
    Actas Urol Esp (Engl Ed); 2018 Mar; 42(2):121-125. PubMed ID: 28911880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major complications following exenteration in cases of pelvic malignancy: a 10-year experience.
    Wydra D; Emerich J; Sawicki S; Ciach K; Marciniak A
    World J Gastroenterol; 2006 Feb; 12(7):1115-9. PubMed ID: 16534855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelvic exenteration for recurrent gynecologic malignancy: a study of 28 consecutive patients at a single institution.
    Jäger L; Nilsson PJ; Rådestad AF
    Int J Gynecol Cancer; 2013 May; 23(4):755-62. PubMed ID: 23407096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of gynecologic oncology patients in King Chulalongkorn Memorial Hospital - complications and outcome of pelvic exenteration.
    Oranratanaphan S; Termrungruanglert W; Sirisabya N
    Asian Pac J Cancer Prev; 2013; 14(4):2529-32. PubMed ID: 23725169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short- and long-term outcomes following pelvic exenteration for gynae-oncological and colorectal cancers: A 9 year consecutive single-centre cohort study.
    Katory M; McLean R; Paez E; Kucukmetin A; Naik R
    Int J Surg; 2017 Jul; 43():38-45. PubMed ID: 28529192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelvic exenteration: factors associated with major surgical morbidity.
    Soper JT; Berchuck A; Creasman WT; Clarke-Pearson DL
    Gynecol Oncol; 1989 Oct; 35(1):93-8. PubMed ID: 2792911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pelvic exenteration: surgical aspects and analysis of early and late morbidity in a series of 106 patients.
    De Wever I
    Acta Chir Belg; 2011; 111(5):273-81. PubMed ID: 22191127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Predictive of 90-Day Morbidity, Readmission, and Costs in Patients Undergoing Pelvic Exenteration.
    Bogani G; Signorelli M; Ditto A; Martinelli F; Casarin J; Mosca L; Leone Roberti Maggiore U; Chiappa V; Lorusso D; Raspagliesi F
    Int J Gynecol Cancer; 2018 Jun; 28(5):975-982. PubMed ID: 29683876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pelvic exenteration in gynecologic oncology: Experience at the Mount Sinai Center, 1975-1992.
    Dottino PR; Segna RA; Jennings TS; Mandeli JP; Konsker K; Cohen CJ
    Mt Sinai J Med; 1995 Nov; 62(6):431-5. PubMed ID: 8692157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laparoscopic pelvic exenteration for gynaecological malignancy: is there any advantage?
    Martínez A; Filleron T; Vitse L; Querleu D; Mery E; Balague G; Delannes M; Soulie M; Pomel C; Ferron G
    Gynecol Oncol; 2011 Mar; 120(3):374-9. PubMed ID: 21215437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Operative mortality and morbidity in pelvic exenteration. Technical aspects].
    De Ranieri J; Crouet H; André M; Souloy J; Desdoits JM; Bouvet A
    J Chir (Paris); 1986 Apr; 123(4):246-50. PubMed ID: 3745309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.